Canopy Growth Introduces Spectrum Therapeutics

SMITHS FALLS, ON, May 7, 2019 /PRNewswire/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (WEED.TO) (CGC) is pleased to introduce Spectrum Therapeutics, a new global brand that will encompass all of the Company’s ongoing commercial medical and clinical research operations including Spectrum Cannabis, Canopy Health Innovations (CHI), and the most recent addition to Canopy Growth’s medical portfolio, Bionorica SE-founded C3 Cannabinoid Compound Company (“C3”), a European leader in cannabinoid-based medical therapies.

READ MORE: https://finance.yahoo.com/news/canopy-growth-introduces-spectrum-therapeutics-123000033.html?.tsrc=rss